Annual Non Current Assets
$367.00 K
-$864.00 K-70.19%
December 31, 2023
Summary
- As of February 7, 2025, RSLS annual long term assets is $367.00 thousand, with the most recent change of -$864.00 thousand (-70.19%) on December 31, 2023.
- During the last 3 years, RSLS annual non current assets has fallen by -$27.75 million (-98.69%).
- RSLS annual non current assets is now -99.51% below its all-time high of $74.77 million, reached on December 31, 2017.
Performance
RSLS Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$277.00 K
-$29.00 K-9.48%
September 30, 2024
Summary
- As of February 7, 2025, RSLS quarterly long term assets is $277.00 thousand, with the most recent change of -$29.00 thousand (-9.48%) on September 30, 2024.
- Over the past year, RSLS quarterly non current assets has dropped by -$151.00 thousand (-35.28%).
- RSLS quarterly non current assets is now -99.63% below its all-time high of $74.77 million, reached on December 31, 2017.
Performance
RSLS Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
RSLS Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -70.2% | -35.3% |
3 y3 years | -98.7% | -99.5% |
5 y5 years | -99.0% | -99.0% |
RSLS Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -98.4% | at low | -98.8% | at low |
5 y | 5-year | -98.8% | at low | -99.5% | at low |
alltime | all time | -99.5% | at low | -99.6% | at low |
ReShape Lifesciences Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $277.00 K(-9.5%) |
Jun 2024 | - | $306.00 K(-8.9%) |
Mar 2024 | - | $336.00 K(-8.4%) |
Dec 2023 | $10.30 M(+3.9%) | $367.00 K(-14.3%) |
Sep 2023 | - | $428.00 K(-67.3%) |
Jun 2023 | - | $1.31 M(+16.7%) |
Mar 2023 | - | $1.12 M(-8.9%) |
Dec 2022 | $9.91 M(-66.9%) | $1.23 M(-91.7%) |
Sep 2022 | - | $14.88 M(-33.7%) |
Jun 2022 | - | $22.44 M(-5.1%) |
Mar 2022 | - | $23.64 M(+4.6%) |
Dec 2021 | $29.94 M(+234.7%) | $22.59 M(-57.5%) |
Sep 2021 | - | $53.11 M(-2.4%) |
Jun 2021 | - | $54.40 M(+95.9%) |
Mar 2021 | - | $27.77 M(-1.2%) |
Dec 2020 | $8.94 M(-11.5%) | $28.12 M(-1.1%) |
Sep 2020 | - | $28.44 M(-0.6%) |
Jun 2020 | - | $28.60 M(-1.6%) |
Mar 2020 | - | $29.05 M(-1.7%) |
Dec 2019 | $10.11 M(+15.9%) | $29.55 M(-3.2%) |
Sep 2019 | - | $30.51 M(-1.8%) |
Jun 2019 | - | $31.06 M(-18.7%) |
Mar 2019 | - | $38.19 M(+1.7%) |
Dec 2018 | $8.72 M(-37.4%) | $37.55 M(-15.4%) |
Sep 2018 | - | $44.39 M(-1.8%) |
Jun 2018 | - | $45.18 M(-38.3%) |
Mar 2018 | - | $73.25 M(-2.0%) |
Dec 2017 | $13.94 M(+143.6%) | $74.77 M(+152.8%) |
Sep 2017 | - | $29.58 M(+1.1%) |
Jun 2017 | - | $29.26 M(+3318.5%) |
Mar 2017 | - | $855.90 K(-35.2%) |
Dec 2016 | $5.72 M(-45.5%) | $1.32 M(+27.2%) |
Sep 2016 | - | $1.04 M(+19.5%) |
Jun 2016 | - | $868.20 K(-4.0%) |
Mar 2016 | - | $904.70 K(-16.5%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | $10.50 M(-19.4%) | $1.08 M(-2.8%) |
Sep 2015 | - | $1.12 M(-17.4%) |
Jun 2015 | - | $1.35 M(+2.8%) |
Mar 2015 | - | $1.31 M(-3.5%) |
Dec 2014 | $13.02 M(-47.9%) | $1.36 M(-6.7%) |
Sep 2014 | - | $1.46 M(-2.4%) |
Jun 2014 | - | $1.50 M(+6.4%) |
Mar 2014 | - | $1.41 M(+0.6%) |
Dec 2013 | $24.99 M(+2.4%) | $1.40 M(-8.4%) |
Sep 2013 | - | $1.53 M(-5.3%) |
Jun 2013 | - | $1.61 M(-4.6%) |
Mar 2013 | - | $1.69 M(-0.2%) |
Dec 2012 | $24.40 M(-22.7%) | $1.69 M(+55.8%) |
Sep 2012 | - | $1.09 M(+5.3%) |
Jun 2012 | - | $1.03 M(+11.0%) |
Mar 2012 | - | $930.20 K(+1.2%) |
Dec 2011 | $31.57 M(-16.5%) | $919.30 K(+44.4%) |
Sep 2011 | - | $636.50 K(-14.3%) |
Jun 2011 | - | $742.90 K(-7.5%) |
Mar 2011 | - | $803.10 K(-9.1%) |
Dec 2010 | $37.80 M(+150.3%) | $883.10 K(-18.8%) |
Sep 2010 | - | $1.09 M(+2.7%) |
Jun 2010 | - | $1.06 M(+3.6%) |
Mar 2010 | - | $1.02 M(-8.0%) |
Dec 2009 | $15.10 M(-43.6%) | $1.11 M(-10.8%) |
Sep 2009 | - | $1.25 M(-2.9%) |
Jun 2009 | - | $1.28 M(-6.9%) |
Mar 2009 | - | $1.38 M(-7.2%) |
Dec 2008 | $26.79 M(-53.4%) | $1.48 M(+8.6%) |
Sep 2008 | - | $1.37 M(-1.0%) |
Jun 2008 | - | $1.38 M(-5.6%) |
Mar 2008 | - | $1.46 M(-2.3%) |
Dec 2007 | $57.55 M(+64.7%) | $1.50 M(-15.8%) |
Sep 2007 | - | $1.78 M(+60.4%) |
Dec 2006 | $34.96 M(+221.2%) | $1.11 M(+63.3%) |
Dec 2005 | $10.88 M | $679.10 K |
FAQ
- What is ReShape Lifesciences annual long term assets?
- What is the all time high annual non current assets for ReShape Lifesciences?
- What is ReShape Lifesciences annual non current assets year-on-year change?
- What is ReShape Lifesciences quarterly long term assets?
- What is the all time high quarterly non current assets for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly non current assets year-on-year change?
What is ReShape Lifesciences annual long term assets?
The current annual non current assets of RSLS is $367.00 K
What is the all time high annual non current assets for ReShape Lifesciences?
ReShape Lifesciences all-time high annual long term assets is $74.77 M
What is ReShape Lifesciences annual non current assets year-on-year change?
Over the past year, RSLS annual long term assets has changed by -$864.00 K (-70.19%)
What is ReShape Lifesciences quarterly long term assets?
The current quarterly non current assets of RSLS is $277.00 K
What is the all time high quarterly non current assets for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly long term assets is $74.77 M
What is ReShape Lifesciences quarterly non current assets year-on-year change?
Over the past year, RSLS quarterly long term assets has changed by -$151.00 K (-35.28%)